ADIPOQ and metabolic syndrome: The association with waist circumference persisted after adjusting for ASCVD and statin use (model 1) but decreased after adjusting for HOMA-IR, adiponectin, C-reactive protein, hypertension status and dyslipidemia status (model 2).